Comparative Approach to the Administration of Patients with Alcohol Dependence in Generalized Schizophrenia and Schizoaffective Disorder


  • S. Sh. Karimova Bukhara state Medical Institute, Uzbekistan



Alcohol addiction, medical problems, schizophrenia, schizoaffective psychosis


Goal of this study of the relationship between alcohol use, severity of psychiatric symptoms and the number of verified medical diagnoses. The study was that self-reporting of medical history is less accurate in patients with comorbid alcohol dependence and schizophrenia compared with patients with alcohol dependence only or with control. 46 patients with schizophrenia or schizoaffective disorder and concomitant alcohol dependence recruited from the Bukhara Regional Psych neurological Dispensary. 27 patients suffered from schizophrenia, and 19 patients from schizoaffective disorder.


Download data is not yet available.


Addington D, Addington J, Matika- Tyndale E. assessing depression in schizophrenia: the calgary depression Scale. Br J Psychiatry Suppl.1993;[22]:39-44.

Koshkina E. A. Epidemiology of drug- related diseases. Guide to narcology. "M...":MedpraktikaPubl., 2002, Vol. 1, Pp. 8-32

Strelets N. V. Clinic and treatment of poly-drug addiction . Lectures on narcology / ed. N. N. Of iwaniec. – M.: MedpractikaPubl., 2001, Pp. 214-222

Rokhlina M. L., Mokhnachev S. O. Mental and behavioral disorders associated with the combined use of drugs and other psychoactive substances. Narcology: a national guide / ed. N. N. Ivants, I. P. Anokhina, and M. A. Vinnikova, Moscow: GEOTAR-Media, 2008, Pp. 320-323

Batki SL, Dimmock JA, Ploutz-Snyder R, Meszaros ZS, Canfield K. directly controlled naltrexone reduces heavy drinking in schizophrenia: a preliminary analysis of a controlled study. Alc Clin Exp Res Suppl. 2009;33[6]: 116A.]

Batki SL, Meszaros ZS, Strutynski K, Dimmock JA, Leontieva L, Ploutz- Snyder R, Canfield K, Drayer R. medical comorbidity in patients with schizophrenia and alcohol dependence. Schizophr Res. 2009;107[2-3]: 139-146.

Capasso RM, Lineberry TW, Bostwick JM, Decker PA, St Sauver J. mortality in schizophrenia and schizoaffective disorder: the County cohortOlmsted, Minnesota: 1950-2005. Schizophr Res. 2008;98[1-3]: 287-294.

Carney CP, Jones L, Woolson RF. Medical comorbidity in women and men with schizophrenia: a population- based controlled study. J Gen Intern Med. 2006;21[11]:1133–1137.

Colton CW, Manderscheid RW. Coincidences in rates of increased mortality, lost years of potential life, and causes of death among government mental health clients in eight States. Prev Chron Dis. 2006;3[2]: A42

De Alba I, Samet JH, Saitz R. burden of medical diseases in drug-and alcohol- dependent individuals without primary health care. I'm An Addict. 2004;13[1]:33–45

Dennis ML, Funk R, Godley SH, Godley MD, Waldron H. cross validation of measures for alcohol and cannabis use in the global individual needs assessment [GAIN] and time feedback [TLFB; form 90] among adolescents receiving treatment психоактивнымиfor substanceabuse. Dependence. 2004;99[2]:120–128.

Dickey B, Normand SL, Weiss RD, Drake RE, Azeni H. medical morbidity, mental illness and substance use disorders. PsychiatristServ. 2002; 53[7]:861-867




How to Cite

Karimova, S. S. . (2022). Comparative Approach to the Administration of Patients with Alcohol Dependence in Generalized Schizophrenia and Schizoaffective Disorder. INTERNATIONAL JOURNAL OF HEALTH SYSTEMS AND MEDICAL SCIENCES, 1(6), 260–263.